//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~subject:"Research-and-development"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject:"Clinical-trial-design"
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Research-and-development
Clinical-trial-design
73
Pharmacoeconomics
67
Cost-analysis
19
Cost-effectiveness
18
Clinical trial design
13
Health-economics
13
Clinical-trial-design-commentary
12
Quality-adjusted-life-years
12
Reviews-on-treatment
12
Quality-of-life
11
Cost-utility
10
Quality-of-life-rating-scales
7
Antihyperglycaemics
6
Statistics
6
Type-2-diabetes-mellitus
6
Alzheimer's-disease
5
Cost analysis
5
Cost-benefit
5
Data-collection
5
Practice-guideline-commentary
5
Access
4
Bayesian-analysis
4
Comparators
4
Diabetes-mellitus
4
EU HTA
4
Endpoints
4
Health-policy
4
Lipids
4
Modelling
4
Patient-relevance
4
Pharmaceutical-industry
4
Willingness-to-pay
4
Antidementias
3
Randomised-controlled-trials
3
Resource-use
3
Theorie
3
Theory
3
Treatment-outcome
3
Adaptive Clinical Trial Design
2
more ...
less ...
Online availability
All
Undetermined
3
Type of publication
All
Article
3
Language
All
Undetermined
3
Author
All
Edwards, Martin
1
Golec, Joseph H.
1
Mayer, Musa
1
Stevens, J. Stedman.
1
Vernon, John A.
1
Published in...
All
PharmacoEconomics
2
The Patient: Patient-Centered Outcomes Research
1
Source
All
RePEc
3
Showing
1
-
3
of
3
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Patient Advocacy in Research: Merely an Afterthought?
Mayer, Musa
- In:
The Patient: Patient-Centered Outcomes Research
4
(
2011
)
2
,
pp. 69-71
Persistent link: https://www.econbiz.de/10010614421
Saved in:
2
Comparative Effectiveness Regulations and Pharmaceutical Innovation
Vernon, John A.
;
Golec, Joseph H.
;
Stevens, J. Stedman.
- In:
PharmacoEconomics
28
(
2010
)
10
,
pp. 877-887
recognition. This is the purpose of the article. To achieve this goal, we develop several models of
clinical
trial
design
, drug …
Persistent link: https://www.econbiz.de/10008519887
Saved in:
3
New Drugs for Osteoporosis: Comparison of the Costs and Required Returns With Those of Other Drugs Intended for Long-Term Use
Edwards, Martin
- In:
PharmacoEconomics
15
(
1999
)
3
,
pp. 269-278
Specific regulatory guidelines dictate that developing a new drug for osteoporosis will be significantly more expensive and take at least 2 years longer in comparison with other long-term therapies developed using the International Committee on Harmonisation (ICH) general guidelines. Assuming...
Persistent link: https://www.econbiz.de/10005590530
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->